Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST001795)

(Analysis AN002915)

Metabolite	Structure	F1	F2	F3
1-O-Octadec-9-enyl glycerol	ME416429	0.90	0.19	1.96
di-n-Undecylamine	ME416427	1.06	0.04	1.43
Tridemorph	ME416707	1.08	0.13	1.69
PC 42:11	ME416634	0.92	NA	1.06
Minabeolide-2	ME416423	0.88	NA	1.08
Pleuromutilin	ME416669	0.90	NA	1.07
[SP amino_dimethyl(18:0)] 2-amino-14_16-dimethyloctadecan-3-ol	ME416422	0.81	NA	1.13
Spisulosine	ME416701	0.77	NA	1.15
PC 40:1	ME416625	1.06	0.13	1.13
PA P-28:0 or PA O-28:1	ME416590	1.07	0.02	1.04
PA 44:1	ME416584	0.95	NA	1.05
PA 36:0	ME416578	0.96	NA	1.04
PA 42:1	ME416582	0.97	NA	1.03
PS P-42:5 or PS O-42:6	ME416681	0.99	NA	1.01
PS O-18:0	ME416674	0.99	NA	1.01
PA 40:1	ME416580	0.99	NA	1.01
PC 24:0	ME416601	0.99	NA	1.01
PC 28:0	ME416602	1.01	NA	0.99
PC 30:2	ME416605	1.01	NA	0.99
Erucicoyl-EA	ME416543	1.03	NA	0.98
PC 42:1	ME416633	1.03	NA	0.98
N-(2-hydroxyoctadecanoyl)-sphinganine	ME416426	1.02	NA	0.98
PA 38:0	ME416579	1.02	NA	0.98
PS P-36:0 or PS O-36:1	ME416676	1.15	0.04	0.96
MG(0:0/22:2(13Z_16Z)/0:0)	ME416425	1.10	NA	0.90
PA 22:0/0:0*	ME416574	1.10	NA	0.90
PA 34:0	ME416577	1.08	NA	0.92
PS O-16:0/22:1(11Z)*	ME416673	1.05	NA	0.95
PA 17:0/14:1*	ME416573	1.07	NA	0.93
LPC 12:0	ME416547	1.06	NA	0.94
N-(2-hydroxyundecanoyl)-phytosphingosine	ME416424	1.06	NA	0.94
PC(16:0/9:0(CHO))	ME416450	1.46	0.49	1.00
PS P-29:0 or PS O-29:1	ME416675	1.45	0.36	1.05
PC 30:1	ME416604	1.34	0.08	1.37
PC 36:1	ME416616	1.34	0.11	1.45
Cer 18:0;O3/15:0;O	ME416527	1.37	0.15	1.20
1-Dodecanoyl-sn-glycerol	ME416428	1.48	0.13	1.29
FA oxo(15:0)	ME416431	1.42	0.21	1.28
PC 38:1	ME416621	1.29	0.24	1.39
PC 34:1	ME416611	1.31	0.27	1.33
PC 30:0	ME416603	1.33	0.25	1.34
PE 40:6	ME416661	1.33	0.24	1.34
PA P-30:0 or PA O-30:1	ME416591	1.25	0.19	1.20
SM 18:1;O2/24:0	ME416685	1.22	0.20	1.22
PA P-34:0 or PA O-34:1	ME416594	1.25	0.17	1.30
PS P-38:1 or PS O-38:2	ME416678	1.29	0.13	1.28
Cer 18:0;O3/13:0;O	ME416526	1.35	0.06	1.06
PA O-28:0	ME416586	1.21	0.25	1.12
PC 32:3	ME416609	1.32	0.24	1.11
PS P-38:2 or PS O-38:3	ME416679	1.15	0.56	1.00
Cer 36:1;O2	ME416534	1.14	0.46	0.98
PC P-40:0 or PC O-40:1	ME416656	1.20	0.46	1.04
Cer 18:0;O2/16:0	ME416522	1.28	0.55	1.11
Cer 18:1;O2/16:0	ME416528	1.24	0.63	1.09
[FA (16:2)] N-hexadecyl-ethanolamine	ME416452	1.24	0.58	1.13
LPC 14:0	ME416548	1.26	0.59	1.11
PC O-34:0	ME416643	1.24	0.60	1.11
PC 34:0	ME416610	1.32	0.61	1.03
[ST (3:0)] cholest-5Z_7Z_24-trien-3beta-ol	ME416459	1.28	0.66	1.02
3-beta-Hydroxy-4-beta-methyl-5-alpha-cholest-7-ene-4-alpha-carboxylate	ME416509	1.22	0.67	1.06
PC 32:0	ME416606	1.22	0.67	1.07
PA P-30:1 or PA O-30:2	ME416592	1.17	0.63	1.04
PS P-36:1 or PS O-36:2	ME416677	1.20	0.65	0.99
PA 40:3	ME416581	1.19	0.41	1.13
N-(2-hydroxyeicosanoyl)-sphinganine	ME416430	1.07	0.37	1.16
PS(P-20:0/22:2(13Z_16Z))	ME416432	1.07	0.45	1.18
Glucosylceramide	ME416437	1.03	0.53	1.28
PC 42:9	ME416640	1.04	0.51	1.34
GlcCer 14:1;O2(4E)/20:0;O	ME416544	1.09	0.53	1.33
Stearamide	ME416702	1.09	0.51	1.34
1-(14-methyl-pentadecanoyl)-2-(8-[3]-ladderane-octanyl)-sn-glycerol	ME416441	1.17	0.51	1.26
SM 36:2;O2	ME416693	1.17	0.51	1.26
FA oxo(21:0)	ME416439	1.16	0.51	1.22
CAR 16:0	ME416519	1.20	0.51	1.23
Cer 18:1;O2/24:0	ME416529	1.18	0.53	1.23
Cer 40:1;O2	ME416535	1.23	0.50	1.21
[SP hydroxy(16:0)] N-(hexadecanoyl)-4S-hydroxysphinganine	ME416446	1.20	0.55	1.20
N-(2-hydroxynonadecanoyl)-phytosphingosine	ME416443	1.23	0.53	1.18
[PC(18:3)]	ME416448	1.25	0.55	1.15
Glucosylceramide (d18:1/22:0)	ME416445	1.12	0.57	1.26
PC 36:3	ME416618	1.14	0.56	1.26
anhydroretinol	ME416442	1.06	0.60	1.26
Glucosylceramide (d18:1/16:0)	ME416444	1.09	0.58	1.29
Cer 18:0;O2/24:0;O	ME416525	1.17	0.60	1.18
[ST Oxo(2:0)] 3-Oxochola-4_6-dien-24-oic Acid	ME416449	1.16	0.58	1.22
PC 36:2	ME416617	1.14	0.63	1.20
LPC 24:0	ME416560	1.11	0.62	1.22
PC 42:5	ME416637	1.09	0.60	1.22
PC 40:9	ME416632	1.12	0.26	1.29
PC 34:4	ME416614	1.25	0.34	1.34
Cer 18:0;O2/22:0	ME416523	1.21	0.35	1.37
PC 38:2	ME416622	1.22	0.38	1.34
PC 38:5	ME416624	1.17	0.41	1.35
PC 40:7	ME416630	1.18	0.40	1.36
PC 36:4	ME416619	1.18	0.45	1.31
Cer 18:0;O2/24:0	ME416524	1.14	0.47	1.33
PC 42:7	ME416638	1.15	0.46	1.34
PC 32:2	ME416608	1.32	0.47	1.15
PA P-34:1 or PA O-34:2	ME416595	1.31	0.31	1.30
PC 32:1	ME416607	1.33	0.31	1.28
Octadecadienal	ME416435	1.38	0.32	1.22
PE 40:7	ME416662	1.35	0.35	1.23
N-(2-hydroxydocosanoyl)-sphinganine	ME416440	1.23	0.46	1.25
PC 34:3	ME416613	1.23	0.43	1.28
PC P-36:0 or PC O-36:1	ME416648	1.31	0.42	1.21
CAR 18:1	ME416521	1.28	0.37	1.28
PC 36:5	ME416620	1.30	0.35	1.28
PC 36:0	ME416615	1.27	0.40	1.26
PC P-38:0 or PC O-38:1	ME416652	1.29	0.40	1.24
Tris(butoxyethyl)phosphate	ME416438	0.88	0.55	1.52
CTAB	ME416433	1.05	0.36	1.52
FA oxo(14:1) cyclopentanebutanoic acid	ME416434	0.98	0.40	1.55
[PC(22:6/22:6)] 1_2-di-(4Z_7Z_10Z_13Z_16Z_19Z-docosahexaenoyl)-sn-glycero-3-phosphocholine	ME416436	1.12	0.40	1.42
PC 40:5	ME416629	1.06	0.43	1.44
PC 40:8	ME416631	1.08	0.42	1.44
PC 38:4	ME416623	1.18	0.31	1.44
Docosanamide	ME416541	1.14	0.33	1.46
Phytosphingosine	ME416668	1.11	0.32	1.49
SM 33:1;O2	ME416688	0.70	1.36	0.98
10_11-Dihydro-12R-hydroxy-leukotriene E4	ME416447	0.93	1.37	0.95
all-trans-13_14-Dihydroretinol	ME416489	0.92	1.25	0.86
[SP (3:0)] sphinga-4E_8E_10E-trienine	ME416487	0.91	1.24	0.88
PC 18:2	ME416599	0.86	1.32	0.86
LPC 18:1	ME416552	0.88	1.29	0.86
SM 39:1;O2	ME416696	0.90	1.29	0.84
Arachidonoyl-EA	ME416514	0.81	1.32	0.90
Magnoshinin	ME416568	0.81	1.25	0.98
LPC 22:5	ME416559	0.87	1.22	0.93
SM 18:2;O2/22:1	ME416686	0.86	1.26	0.91
PC O-20:0	ME416641	0.93	1.32	0.78
14:4(2E_4E_8E_10E)(6Me[S]_9Me_12Me[S])	ME416492	0.91	1.35	0.74
14^-apo-beta-Carotenal	ME416507	0.92	1.35	0.76
PC P-36:4 or PC O-36:5	ME416651	0.76	1.46	0.83
LPC 20:0	ME416553	0.86	1.39	0.79
5beta-cholestan-3alpha_4alpha_11beta_12beta_21-pentol-3_21-disulphate	ME416490	0.82	1.43	0.82
SM 41:1;O2	ME416699	0.79	1.40	0.85
SM(d17:1/24:1(15Z))	ME416491	0.83	1.38	0.83
LPE 20:2	ME416565	0.80	1.49	0.77
4-Dodecylphenol	ME416511	0.85	1.48	0.73
CAR 14:0	ME416517	0.83	1.47	0.75
Retinol	ME416683	0.88	1.48	0.69
3_5_7-Trimethyl-2E_4E_6E_8E-decatetraene	ME416493	0.91	1.44	0.69
Eicosanoyl-EA	ME416542	0.92	1.41	0.71
Cer 35:0;O2	ME416533	1.23	1.25	0.52
Tributyl phosphate	ME416705	1.15	1.18	0.69
CAR 14:1	ME416518	1.11	1.12	0.78
Margaroyl-EA	ME416569	1.11	1.16	0.75
FA oxo(19:0)	ME416494	1.03	1.42	0.60
beta-Estradiol	ME416515	1.03	1.32	0.69
Retinal	ME416682	1.00	1.36	0.64
3Z_6Z_9Z-Tricosatriene	ME416476	0.83	0.84	1.50
PC 42:2	ME416635	0.88	1.08	1.05
PE 42:3	ME416663	0.84	1.13	1.05
Cer 33:1;O2	ME416532	0.86	1.14	1.02
SM 35:1;O2	ME416691	0.88	1.12	1.01
DG 42:9	ME416540	0.81	1.03	1.13
PE 42:4	ME416664	0.78	1.13	1.11
PA O-34:0	ME416589	1.09	0.88	0.98
SM 40:1;O2	ME416697	1.11	0.90	0.98
SM 42:3;O2	ME416700	1.08	0.88	1.02
SM(d18:1/24:1(15Z))	ME416469	1.06	0.90	1.03
ubiquinol-1	ME416470	0.97	0.95	1.08
LPC 16:1(9Z)*	ME416550	0.97	0.97	1.06
PA O-32:0	ME416588	0.95	0.96	1.07
PC P-36:3 or PC O-36:4	ME416650	0.95	0.97	1.07
PC P-22:3 or PC O-22:4	ME416644	1.02	0.96	1.01
PA P-32:1 or PA O-32:2	ME416593	1.03	0.95	1.01
PA P-34:2 or PA O-34:3	ME416596	1.03	0.95	1.02
N-(2-hydroxy-docosanoyl)-pentadecasphing-4-enine-1-phosphoethanolamine	ME416472	1.02	0.94	1.04
Cer 41:1;O2	ME416537	1.00	0.95	1.04
[ST] (5Z_7E)-9_10-seco-5_7_10(19)-cholestatriene	ME416473	1.00	0.96	1.04
Tremetone	ME416704	1.01	0.88	1.09
8-hydroxy-13Z-octadecene-9_11-diynoic acid	ME416467	1.03	0.90	1.05
Phenylpyruvic acid	ME416667	1.01	0.92	1.06
Falcarindiol	ME416488	1.00	1.19	0.83
LPC 20:2	ME416555	0.93	1.14	0.94
[PI(18:1)] 1-(9Z-octadecenoyl)-sn-glycero-3-phospho-(1^-myo-inositol)	ME416485	0.98	1.15	0.89
[SP] (3^-sulfo)Galbeta-Cer(d18:0/2-OH-18:0)	ME416484	0.97	1.15	0.90
Cholestenone	ME416538	0.94	1.18	0.90
LPC P-18:1 or LPC O-18:2	ME416562	0.95	1.19	0.89
PC P-38:1 or PC O-38:2	ME416653	0.96	1.03	1.01
SP (4:0)	ME416474	0.97	1.03	1.01
Cer 41:0;O2	ME416536	0.95	1.05	1.01
SM 40:2;O2	ME416698	0.94	1.04	1.02
Estradiol-17-phenylpropionate	ME416481	0.99	1.08	0.94
LPC 20:1	ME416554	0.98	1.11	0.92
LPC 16:0	ME416549	1.00	1.04	0.97
4-8dimethylnonanoylcarnitine	ME416479	1.00	1.05	0.96
Linoleamide	ME416546	1.00	1.05	0.96
[FA hydroxy(20:4)] eicosatetraenoyl amine	ME416480	0.97	1.07	0.97
PC P-36:1 or PC O-36:2	ME416649	0.96	1.08	0.97
2-Aminotetradecanoic acid	ME416508	1.10	1.07	0.84
PA 44:6	ME416585	1.07	1.00	0.93
N-(2-hydroxyoctadecanoyl)-phytosphingosine	ME416465	1.08	0.98	0.94
Phencyclidine	ME416666	1.09	0.99	0.92
PC 22:1	ME416600	1.04	1.03	0.93
Xestoaminol C	ME416708	1.02	1.06	0.93
LPE 16:0	ME416563	1.04	1.08	0.89
PA 42:10	ME416583	1.07	1.04	0.90
(1R_4S)-fenchan-2-one	ME416478	1.14	0.96	0.90
N-(2-hydroxyicosanoyl)-phytosphingosine	ME416455	1.15	0.91	0.89
4_8-Dimethyl-1_3E_7-nonatriene	ME416477	1.16	0.94	0.89
FA (14:2) tetradecadienal	ME416475	1.17	0.92	0.90
MG 14:0	ME416570	1.25	0.75	0.97
SM(d18:0/24:1(15Z))	ME416466	1.23	0.77	0.98
Cer 18:1;O2/24:1	ME416530	1.15	0.80	1.02
PC(o-22:0/20:4(8Z_11Z_14Z_17Z))	ME416454	1.14	0.76	1.02
PC P-42:4 or PC O-42:5	ME416660	1.14	0.84	1.00
[FA (18:2)] 3Z_13Z-octadecadien-1-ol	ME416468	1.17	0.84	0.97
Hexadecenal	ME416471	1.19	0.85	0.94
PC 42:8	ME416639	0.98	0.64	1.34
1-eicosanoyl-(1-cyano-2-methylprop-2-en-1-ol)	ME416453	0.98	0.70	1.28
PS 17:1	ME416671	0.98	0.67	1.31
PC 40:3	ME416627	1.16	0.66	1.14
SM 36:1;O2	ME416692	1.15	0.71	1.11
Tridecylic acid	ME416706	1.15	0.74	1.08
Glucosylceramide (d18:1/24:1(15Z))	ME416456	1.06	0.70	1.21
SM 18:0;O2/16:0	ME416684	1.07	0.68	1.22
Himbacine	ME416458	1.06	0.74	1.17
PC P-40:3 or PC O-40:4	ME416659	1.05	0.75	1.17
PS P-40:2 or PS O-40:3	ME416680	1.02	0.74	1.19
SM 34:1;O2	ME416689	1.03	0.76	1.18
PC 40:4	ME416628	1.04	0.74	1.19
SM 38:1;O2	ME416694	1.04	0.75	1.18
PS 34:0	ME416672	1.01	0.85	1.14
PC P-40:2 or PC O-40:3	ME416658	1.03	0.80	1.15
haematoporphyrin IX	ME416462	1.04	0.81	1.14
SM 38:2;O2	ME416695	1.03	0.81	1.14
PA O-30:0	ME416587	1.03	0.80	1.11
N-Acetyl-beta-glucosaminylamine	ME416571	1.05	0.82	1.11
PC 34:2	ME416612	1.05	0.82	1.11
PC P-32:0 or PC O-32:1	ME416645	1.03	0.82	1.13
PC P-38:2 or PC O-38:3	ME416654	1.04	0.82	1.12
PC O-32:0	ME416642	1.07	0.80	1.11
SM 34:2;O2	ME416690	1.08	0.81	1.09
3_5_7-Trimethyl-2E_4E_6E_8E-undecatetraene	ME416463	1.11	0.80	1.06
LPC 24:1(15Z)*	ME416561	1.10	0.80	1.08
PC P-40:1 or PC O-40:2	ME416657	1.10	0.79	1.09
LPC 22:0	ME416558	1.09	0.73	1.15
PC P-38:4 or PC O-38:5	ME416655	1.07	0.77	1.14
LPC 20:3	ME416556	1.08	0.76	1.13
LPC 20:4	ME416557	1.09	0.77	1.12
acyl phosphatidylglycerol (n-C12:0)	ME416460	1.13	0.74	1.11
9_12-Hexadecadienoylcarnitine	ME416461	1.11	0.76	1.10
PC P-34:0 or PC O-34:1	ME416646	1.11	0.76	1.11
LPC 18:0	ME416551	1.10	0.75	1.12
Oleamide	ME416572	1.10	0.74	1.13
Hymenoflorin	ME416545	0.91	0.91	1.27
PE 42:6	ME416665	0.97	0.87	1.14
N_N-Dimethylsphing-4-enine	ME416464	0.95	0.89	1.14
PC 40:2	ME416626	0.96	0.88	1.15
alpha-Linolenoyl-EA	ME416512	0.96	0.82	1.20
(9S_10S)-10-Hydroxy-9-(phosphonooxy)octadecanoate	ME416451	0.93	0.79	1.19
PC 42:4	ME416636	0.97	0.78	1.18
N-(5-hydroxy-pentyl)-5Z_8Z_11Z_14Z-eicosatetraenoyl amine	ME416457	0.92	0.77	1.29
SM 32:1;O2	ME416687	0.96	0.77	1.25
Altretamine	ME416513	1.83	0.78	0.37
Burseran	ME416516	1.79	0.88	0.33
Dihydroceramide	ME416486	1.23	1.02	0.75
[SP hydroxy_hydroxy_methyl(10:2/2:0)] 6R-(8-hydroxydecyl)-2R-(hydroxymethyl)-piperidin-3R-ol	ME416483	1.25	0.98	0.77
3-Dimethylallyl-4-hydroxymandelic acid	ME416482	1.34	0.91	0.75
CAR 16:1;OH	ME416520	1.41	0.89	0.68
Cer 33:0;O2	ME416531	1.53	0.95	0.52
Tetrapentylammonium	ME416703	1.51	1.19	0.48
[SP dimethyl_amino(18:0/2:0)] 2S-dimethylaminooctadecane-1_3R-diol	ME416505	0.56	1.22	NA
PA 30:3	ME416576	0.64	1.63	0.59
[FA (17:1)] 7-heptadecynoic acid	ME416495	0.66	1.76	0.67
LPE 20:0	ME416564	0.65	1.78	0.66
PC P-34:1	ME416647	0.64	1.79	0.66
Coniferyl alcohol	ME416539	0.68	1.70	0.70
3-Ketosphingosine	ME416510	0.70	1.67	0.70
LPE 22:1	ME416567	0.73	1.66	0.69
PA P-34:3 or PA O-34:4	ME416597	0.79	1.58	0.70
7_10_13_16-Docosatetraenoylethanolamine	ME416496	0.86	1.62	0.58
PA P-34:4 or PA O-34:5	ME416598	0.76	1.68	0.56
Antibiotic TA	ME416500	0.37	1.93	0.57
N-(11Z_14Z-eicosadienoyl)-ethanolamine	ME416501	0.57	2.15	0.40
[SP methyl(2:0)] 9-methyl-sphinga-4E_8E-dienine	ME416499	0.59	2.05	0.47
Sphinganine(d17:0)Ê	ME416498	0.72	1.89	0.49
Noladin Ether	ME416497	0.59	1.94	0.53
PA 26:0	ME416575	0.60	1.89	0.61
16alpha-Hydroxysteroid	ME416504	0.19	2.89	0.13
[FA methyl(18:0)] 9_10-methylene-9-octadecenoic acid	ME416503	0.43	2.42	0.31
LPE 22:0	ME416566	0.40	2.31	0.43
[FA (17:3)] 8Z_11Z_14Z-heptadecatrienoic acid	ME416502	0.40	2.37	0.38
Prosopinine	ME416670	0.41	2.35	0.39

Factors:

F1	Treatment:Celecoxib_HFD
F2	Treatment:CFD
F3	Treatment:HFD

Data matrix